Mandate

Vinge advises Komatsu Forest on acquisition of Log Max

October 23, 2012

Vinge is advising Komatsu Forest AB in connection with the acquisition of Log Max AB and Log Max AB’s US subsidiary Log Max Inc. Komatsu Forest AB is a wholly-owned subsidiary to Komatsu Ltd., who manufactures and sells construction and mining equipment, utilities, forest machines and industrial machinery, with a turnover of approx. USD 21bn. and approx. 44,000 employees, and who is listed inter alia on the Tokyo stock exchange. Log Max, with head office in Grangärde, manufactures and sells equipment for mechanized forestry operations and in particular grapple harvesters - a device that will grip and fell a tree, and cut it to desired lengths.

Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

The Vinge team included partners Carl Gustaf De Geer and Malin Ohlin, and associates Nina Farrahi and Peter Sundgren (M&A), associates Christian Hybinette and Eric Ödling (commercial agreements), partner Marcus Glader and associate Peter Alstergren (EU and competition law), associate Johan Cederblad (environmental law), associate Claes Henriksson (IP law), and associate Emma Lindelöf (employment law).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025